Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways

• Hoofdauteurs: Hailong Li (Auteur), Jinhe Li (Auteur), Ting Xiao (Auteur), Yayue Hu (Auteur), Ying Yang (Auteur), Xiaoting Gu (Auteur), Ge Jin (Auteur), Hailong Cao (Auteur), Honggang Zhou (Auteur), Cheng Yang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The super-enhancer, a cluster of enhancers with strong transcriptional activity, has become one of the most interesting topics in recent years. This study aimed to investigate pathogenic super-enhancer-driven genes in IBD and screen therapeutic drugs based on the results. In this study, through the...